CytomX Therapeutics (CTMX) Tax Provisions (2015 - 2026)
CytomX Therapeutics (CTMX) reported Tax Provisions of $59000.0 for Q1 2026, down 4.84% on a YoY basis from $62000.0 in Q1 2025, and up 9.26% quarter-over-quarter from $54000.0 in Q4 2025.
CytomX Therapeutics (CTMX) Tax Provisions (2015 - 2026) Analysis & Trends
CytomX Therapeutics has reported Tax Provisions for 10 years, with the latest figure at $59000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 4.84% year-over-year to $59000.0; the trailing twelve-month figure through Mar 2026 stood at $234000.0 (down 0.85% YoY), and the FY2025 full-year result was $238000.0, up 6.25% from the prior year.
- Tax Provisions for Q1 2026 stood at $59000.0, up from $54000.0 in the prior quarter.
- The five-year high for Tax Provisions was $2.8 million in Q3 2023, with the low at $49000.0 in Q1 2024.
- Historically, Tax Provisions has averaged $401000.0 across 4 years, with a median of $61000.0 in 2024.
- Annual changes were most pronounced in 2024 — Tax Provisions plunged 97.84% — and 2025, when it grew 26.53%.
- CytomX Therapeutics' Tax Provisions stood at $1.1 million in 2023, then sank by 94.2% to $62000.0 in 2024, then decreased by 12.9% to $54000.0 in 2025, then gained by 9.26% to $59000.0 in 2026.
- The last three Tax Provisions figures came in at $59000.0 (Q1 2026), $54000.0 (Q4 2025), and $58000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | CytomX Therapeutics | 520.30 Mn | 173.59 Mn | - | 59,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59,000.00 |
| Dec 31, 2025 | 54,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 63,000.00 |
| Mar 31, 2025 | 62,000.00 |
| Dec 31, 2024 | 62,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Jun 30, 2024 | 51,000.00 |
| Mar 31, 2024 | 49,000.00 |
| Dec 31, 2023 | 1.07 Mn |
| Sep 30, 2023 | 2.82 Mn |
| Mar 31, 2020 | -13.91 Mn |
| Dec 31, 2019 | -384,000.00 |
| Mar 31, 2019 | -6,000.00 |
| Dec 31, 2018 | 8.91 Mn |
| Sep 30, 2018 | 2.50 Mn |
| Jun 30, 2018 | 1.80 Mn |
| Mar 31, 2018 | 1.10 Mn |
| Dec 31, 2017 | -6,000.00 |
| Sep 30, 2017 | -19,000.00 |